1. Home
  2. INAB vs NAAS Comparison

INAB vs NAAS Comparison

Compare INAB & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • NAAS
  • Stock Information
  • Founded
  • INAB 2016
  • NAAS 2019
  • Country
  • INAB United States
  • NAAS China
  • Employees
  • INAB N/A
  • NAAS N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • NAAS Other Specialty Stores
  • Sector
  • INAB Health Care
  • NAAS Consumer Discretionary
  • Exchange
  • INAB Nasdaq
  • NAAS Nasdaq
  • Market Cap
  • INAB 9.1M
  • NAAS 8.3M
  • IPO Year
  • INAB 2021
  • NAAS 2017
  • Fundamental
  • Price
  • INAB $2.00
  • NAAS $3.84
  • Analyst Decision
  • INAB Strong Buy
  • NAAS
  • Analyst Count
  • INAB 2
  • NAAS 0
  • Target Price
  • INAB $108.00
  • NAAS N/A
  • AVG Volume (30 Days)
  • INAB 45.9K
  • NAAS 127.5K
  • Earning Date
  • INAB 11-11-2025
  • NAAS 09-05-2025
  • Dividend Yield
  • INAB N/A
  • NAAS N/A
  • EPS Growth
  • INAB N/A
  • NAAS N/A
  • EPS
  • INAB N/A
  • NAAS N/A
  • Revenue
  • INAB N/A
  • NAAS $27,534,354.00
  • Revenue This Year
  • INAB N/A
  • NAAS $378.49
  • Revenue Next Year
  • INAB N/A
  • NAAS N/A
  • P/E Ratio
  • INAB N/A
  • NAAS N/A
  • Revenue Growth
  • INAB N/A
  • NAAS N/A
  • 52 Week Low
  • INAB $1.91
  • NAAS $1.96
  • 52 Week High
  • INAB $16.70
  • NAAS $74.40
  • Technical
  • Relative Strength Index (RSI)
  • INAB 39.35
  • NAAS 66.08
  • Support Level
  • INAB $1.91
  • NAAS $2.69
  • Resistance Level
  • INAB $2.20
  • NAAS $3.33
  • Average True Range (ATR)
  • INAB 0.11
  • NAAS 0.31
  • MACD
  • INAB -0.01
  • NAAS 0.07
  • Stochastic Oscillator
  • INAB 23.08
  • NAAS 87.79

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.

Share on Social Networks: